(Midterm) Tablets/Capsules Flashcards
Which of the following is NOT correctly matched?
a. Nitrostat – Tablet for oral ingestion
b. Minidiab-OD – Extended-release tablet
c. Bonamine – Chewable tablet
d. Claritin Reditabs – Instant disintegrating tablet
e. Neozep – Multiple-compressed tablet
Nitrostat – Tablet for oral ingestion
A type of stability test, which involves temperatures in 10-degree increments. This test is performed to identify the products of degradation of a product
Stress Test
For rapid disintegration of compressed tablets, the concentration starch to used is;
10-15%
A type of gelatin blend, which contributes to plasticity and clarity to the blend, thus reducing haze or cloudiness of the finished capsules
Pork skin gelatin
This substance is used as an opaquant for gelatin capsule shells
Titanium dioxide
Examples of primary packaging components
a. Rubber stoppers
b. Cotton fillers
c. Blister/strip packs
d. both a and b
both a and b
A tablet formulation contains 2 actives, which are chemically incompatible. The best method to be used is;
Multilayered compression
Strip-sealed tablets are evaluated for
leakers
When preparing hard gelatin capsules, the formulator is not generally concerned with
Powder compaction
Hard gelatin capsules are
1. Commonly employed in clinical trials
2. In small scale compounding, pharmacist uses “punch method”
3. Can be prepared by rotary die process
1,2 are correct
Soft gelatin capsules
1. Are used to hermetically seal and encapsulate liquids, suspensions, and pasty materials
2. Render elastic and plastic-like by adding titanium dioxide
3. Contain more moisture than hard gelatin capsule
1 and 3 are correct
An ideal property of tablet granulations in which the material forms a stable, compact mass when pressure is applied;
Compressibility
The cause of capping, chipping and lamination of compressed tablets
Poor flow rate of granulations
Most biological are store at this temperature
2-8 degree C
Characteristics of added substances to capsule formulation
1. Harmless in quantities used
2. Do not interfere with requisite compendial assays and tests
3. Do not impair product’s bioavailability, therapeutic efficacy or safety
1,2,3 are correct